Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis

OBJECTIVE: Deferiprone is an iron chelator that has recently been used to treat patients with infratentorial superficial siderosis (iSS). It is considered to have a generally favourable safety profile but concerns have been raised due to the risk of agranulocytosis. We aimed to evaluate the safety a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sammaraiee, Y., Banerjee, G., Farmer, S., Hylton, B., Cowley, P., Eleftheriou, P., Porter, J., Werring, D. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954889/
https://www.ncbi.nlm.nih.gov/pubmed/31620867
http://dx.doi.org/10.1007/s00415-019-09577-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954889/
https://www.ncbi.nlm.nih.gov/pubmed/31620867
http://dx.doi.org/10.1007/s00415-019-09577-6

Ejemplares similares